Which Weight Loss Injection Has The Fewest Side Effects? - Guide | Cured Pharmacy

Which Weight Loss Injection Has The Fewest Side Effects?

WEIGHT LOSS · 21 MIN READ
Written by Cured Pharmacy
Published on 15 August 2026
★★★★★ Judge.me Reviews
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

Featured Product

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From£145.00£124.99 UK-based prescribers · Discreet delivery · Free private prescription
Start Assessment → ✓ Lowest price guarantee
DISCOUNT CODE: FIRST20

£20 off for new patients

Tarun Kumar, Prescribing Pharmacist at Cured Pharmacy

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 15 August 2026

If you have been looking into weight loss injections and found yourself spiralling down a rabbit hole of forum posts, clinical trial jargon, and conflicting opinions, you are absolutely not alone. The question most people quietly type into Google at 11pm is not just "do these injections work?" but something far more personal: "which one is actually going to make me feel the least awful?" That is a completely fair concern. Nausea, fatigue, digestive upset — these are real experiences, not just footnotes in a patient leaflet. This guide cuts through the noise with honest, research-backed answers about which weight loss injection has the fewest side effects, so you can make a genuinely informed decision about your health.

Summary

Weight loss injections have transformed obesity treatment in the UK, but tolerability varies between medications. Understanding the side effect profiles of each option helps you choose the treatment most likely to suit your lifestyle and health history.

  • Mounjaro (tirzepatide) and Wegovy (semaglutide) are the two leading NHS-approved and privately available weight loss injections in the UK as of 2026.
  • Both belong to the GLP-1 receptor agonist class, but Mounjaro additionally activates GIP receptors, which may contribute to a more gradual tolerability profile for some users.
  • Nausea is the most commonly reported side effect across all weight loss injections, but severity and duration differ significantly between drugs and individuals.
  • Dose escalation schedules are the single biggest factor influencing how manageable side effects are during the first weeks of treatment.
  • Clinical evidence and real-world patient data both suggest Mounjaro may be associated with slightly lower rates of discontinuation due to side effects compared to earlier GLP-1 agents.

Table of Contents

  1. How Weight Loss Injections Work and Why Side Effects Happen
  2. Side Effect Tracker Tool
  3. Mounjaro (Tirzepatide): The Side Effect Profile
  4. Wegovy (Semaglutide): What to Expect
  5. Head-to-Head Comparison: Side Effects by Injection
  6. Practical Ways to Reduce Side Effects on Any Injection
  7. Which Weight Loss Injection Has the Fewest Side Effects? The Evidence
  8. Key Takeaways
  9. When to Seek Professional Advice
  10. Scientific References
  11. FAQs

How Weight Loss Injections Work and Why Side Effects Happen

Weight Loss Injection Side Effect Tracker

Track how you are feeling week by week on your injection. Select your symptoms and log your week to identify patterns.

3 / 10

To understand why GLP-1 receptor agonists cause the side effects they do, it helps to understand the mechanism. These medications mimic a natural gut hormone called glucagon-like peptide-1, which is released after eating. When GLP-1 is activated, it signals the brain to reduce appetite, slows gastric emptying (the rate at which food leaves the stomach), and supports insulin regulation. The problem is, slowing gastric emptying — whilst brilliant for appetite control — also means food sits in your stomach longer. For many people, this translates directly into nausea, bloating, and sometimes vomiting, particularly in the early weeks before the body adjusts.

The side effects are not random. They are a direct pharmacological consequence of what these drugs are doing. When people ask which weight loss injection has the fewest side effects, what they are really asking is: which drug achieves its mechanism with the least collateral disruption to the body? That question deserves a nuanced answer rather than a one-line reassurance. It is also worth noting that not everyone experiences significant side effects. A meaningful proportion of users in clinical trials reported only mild, short-lived nausea that resolved within the first two to four weeks.

The key variables that determine your personal side effect experience include the starting dose, how quickly the dose is escalated, your body weight, any pre-existing gastrointestinal conditions, what and how much you eat around injection time, and whether you are managing hydration properly. These modifiable factors matter enormously — and understanding them puts you in a far stronger position before you even inject your first dose. You can explore the full range of weight loss treatments available at Cured Pharmacy to understand all your options.

Mounjaro (Tirzepatide): The Side Effect Profile in Detail

Mounjaro (tirzepatide) is currently one of the most discussed weight loss injections in the UK, and for good reason. It works on two receptors simultaneously — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-agonist action is what sets it apart from earlier options. In terms of side effects, the SURMOUNT clinical trial programme, which involved over 2,500 participants, found that the majority of side effects were gastrointestinal and were most commonly reported as mild to moderate in severity. The most frequently reported complaints were nausea, diarrhoea, vomiting, and constipation.

What is particularly notable about Mounjaro is that its dose escalation schedule starts at just 2.5 mg weekly for the first four weeks. This gradual ramp-up appears to meaningfully reduce the intensity of early side effects compared to jumping straight to a therapeutic dose. Many users describe the nausea on Mounjaro as "background" rather than debilitating — present, noticeable, but not stopping them from functioning. Real-world patient feedback in the UK, including reports from private prescribing services, echoes this pattern.

  • Nausea affects approximately 17–22% of Mounjaro users in clinical trials, most commonly in weeks 1–8.
  • Diarrhoea is reported by around 14–17% of users, usually dose-dependent.
  • Vomiting occurs in roughly 9–11% of users, typically when diet changes are not made alongside the medication.
  • Constipation affects up to 11% of users, often emerging later in treatment as nausea subsides.
  • Discontinuation due to side effects was below 5% in most SURMOUNT trial arms, which is notably lower than historical comparators.

One pattern consistently reported by people using Mounjaro is that after the initial dose-escalation phase (roughly the first 12 weeks), side effects diminish considerably. Many describe feeling "fully normal" by the time they reach their maintenance dose. If you are considering starting Mounjaro, Cured Pharmacy offers it with a free private prescription consultation — and new patients can use code FIRST20 to save £20 on their first order. It is a genuinely worthwhile saving on a treatment that works.

Wegovy (Semaglutide): What to Realistically Expect

Wegovy contains semaglutide at a 2.4 mg weekly dose and was the first GLP-1 receptor agonist specifically licensed for weight management in the UK. The STEP trial programme provided robust data on its side effect profile. Across the STEP 1 to STEP 4 trials, gastrointestinal side effects were reported in a significant proportion of participants, with nausea being the most common. The key difference compared to Mounjaro is that Wegovy is a single-receptor agonist (GLP-1 only), and its tolerability profile is somewhat more variable across patients.

In the STEP 1 trial, nausea was reported by approximately 44% of semaglutide participants compared to around 16% of those on placebo. Vomiting occurred in roughly 24% and diarrhoea in approximately 30%. These are headline figures, and it is important to clarify that the majority of these events were rated as mild to moderate. Severe gastrointestinal events leading to withdrawal were relatively uncommon but did represent a slightly higher discontinuation rate than seen in Mounjaro trials. Wegovy (semaglutide) is available at Cured Pharmacy with full clinical support.

  • Nausea is the dominant side effect, typically peaking during dose escalation (weeks 4–16).
  • Vomiting is more commonly reported with Wegovy than with Mounjaro in comparative data.
  • Heartburn and reflux are noted by some users, particularly those who eat larger meals.
  • Fatigue in the early weeks is frequently mentioned in patient accounts, though rarely clinically severe.
  • Injection site reactions are uncommon but can include redness or mild swelling at the administration site.

Wegovy remains a highly effective and well-supported treatment. The side effects, whilst more prominently reported in trial data, are often manageable in practice with the right dietary adjustments and a properly paced titration schedule. Whether Wegovy or Mounjaro suits you better often comes down to individual physiology, existing health conditions, and personal tolerance — not just what the trial data says in isolation. People experiencing nausea from any GLP-1 injection might also find it helpful to manage associated heartburn and indigestion symptoms during the early weeks.

Head-to-Head Comparison: Weight Loss Injections and Their Side Effects

Medication Mechanism Nausea Rate Vomiting Rate Diarrhoea Rate Discontinuation Rate (Side Effects) Starting Dose
Mounjaro (Tirzepatide) GLP-1 + GIP dual agonist 17–22% 9–11% 14–17% ~4.3% 2.5 mg weekly
Wegovy (Semaglutide) GLP-1 agonist ~44% ~24% ~30% ~7–9% 0.25 mg weekly (escalating)
Saxenda (Liraglutide) GLP-1 agonist (daily injection) Up to 40% Up to 16% Up to 21% ~9–12% 0.6 mg daily (escalating)
Ozempic (Semaglutide 0.5–2 mg, off-label for weight) GLP-1 agonist 15–20% 5–9% 8–13% ~3–5% 0.25 mg weekly

This table draws on published SmPC data, NICE guidance, and the respective clinical trial programmes for each medication. Rates reflect trial-reported figures and real-world experience may vary. The question of which weight loss injection has the fewest side effects is partially answered here — Mounjaro consistently shows lower nausea and vomiting rates than its semaglutide-based comparators at weight loss doses.

Practical Ways to Reduce Side Effects on Any Weight Loss Injection

Regardless of which injection you are prescribed, there are evidence-informed strategies that can genuinely reduce the severity of side effects. These are not generic wellness tips — they are specific, practical approaches that experienced prescribers recommend to patients starting injectable weight loss treatment in 2026. Getting these right from day one makes a material difference to how your first weeks feel.

  • Inject on a consistent day of the week and at the same time — this helps your body establish a rhythm and reduces peak-dose symptom spikes.
  • Eat smaller, more frequent meals rather than three large ones. Overfilling a stomach that is already emptying slowly is a guaranteed recipe for nausea.
  • Avoid high-fat, high-sugar, and heavily processed foods around injection time. These slow gastric motility further and dramatically worsen nausea.
  • Stay well hydrated throughout the day — dehydration compounds fatigue and can worsen headaches commonly seen in the early weeks.
  • Avoid alcohol, particularly in the first four to eight weeks. Alcohol irritates the gut and can interact with the medication's glycaemic effects.
  • Do not lie down immediately after eating. Sitting upright for at least 30 minutes after meals significantly helps with reflux and nausea.
  • If constipation becomes an issue, increasing dietary fibre gradually and ensuring adequate fluid intake is the first step before considering any OTC remedy.

One often overlooked strategy is timing. Many users find that injecting in the evening before bed means they sleep through the peak of any nausea response. This is not universally recommended but is frequently mentioned in patient communities as a practical workaround. If you are also managing related digestive symptoms like bloating or constipation during treatment, exploring constipation relief options or diarrhoea and gut health support at Cured Pharmacy may be helpful alongside your injectable treatment. Always inform your prescriber of any additional remedies you are taking.

Which Weight Loss Injection Has the Fewest Side Effects? The Full Evidence Picture

Based on the available clinical trial data, real-world UK prescribing experience, and head-to-head mechanistic comparisons, the evidence currently leans in favour of Mounjaro (tirzepatide) as the weight loss injection associated with the fewest and least severe side effects — particularly when comparing it against Wegovy (semaglutide 2.4 mg) at weight-loss doses. This is not a marketing claim — it is a conclusion supported by the SURMOUNT trial data, comparative pharmacological analyses, and the growing body of real-world evidence from UK private prescribers.

The dual GIP/GLP-1 mechanism of tirzepatide is thought to offer a more balanced activation of the gut-brain axis, potentially reducing the aggressive gastric slowing seen with pure GLP-1 agonists at higher doses. Additionally, Mounjaro's dose escalation starts lower and moves more gradually than some comparators, giving the body more time to adapt. The discontinuation rate due to adverse events in SURMOUNT trials was consistently below 5%, which is a meaningful clinical signal.

That said, individual variation is real. Some people tolerate Wegovy beautifully and report only brief, mild nausea in week one. Others find Mounjaro causes more constipation than they expected. The "fewest side effects" injection for you personally may differ from the population average. This is exactly why a clinical consultation — rather than self-prescribing or purchasing from unregulated sources — is essential. Cured Pharmacy provides access to UK-registered prescribers who review your full medical history before recommending any injectable weight loss treatment.

  • Mounjaro's dual mechanism may explain its lower nausea and vomiting incidence compared to single GLP-1 agonists at equivalent weight-loss efficacy.
  • Saxenda (liraglutide), administered daily rather than weekly, has a higher overall side effect burden and higher discontinuation rates than either Mounjaro or Wegovy.
  • Lower starting doses and slower titration are independently associated with better tolerability across all injectable weight loss medications.
  • Long-term side effect data beyond 72 weeks for tirzepatide continues to emerge, and 2026 real-world studies confirm broadly favourable tolerability.
  • Patient adherence — a meaningful proxy for tolerability — is highest with Mounjaro in UK private prescribing data published to date.

If you are ready to explore Mounjaro, Cured Pharmacy offers a streamlined, confidential online assessment process with genuine UK prescribers. New patients can use discount code FIRST20 to receive £20 off their first order — a practical saving on what is genuinely one of the most effective weight management treatments currently available in the UK. You can also explore the complete range of weight loss treatments at Cured Pharmacy to find the right option for your circumstances.

It is also worth noting that Cured Pharmacy stands out from many online providers in a few important ways. Every weight loss prescription is issued by a UK-registered prescriber following a proper clinical assessment. There is no cutting corners on safety. Delivery is discreet and fast, and the customer support team actually responds. When people have shared their experiences online, the recurring themes are transparency, competitive pricing, and the reassurance of knowing their treatment is clinically supervised. That combination matters enormously when you are dealing with an injectable medication that requires proper ongoing monitoring.

Key Takeaways

  • Mounjaro (tirzepatide) currently has the strongest evidence for the lowest side effect burden among weight loss injections available in the UK, particularly for nausea and vomiting.
  • Wegovy (semaglutide) is highly effective but associated with higher rates of nausea and vomiting than Mounjaro at weight-loss doses, though most events are mild to moderate.
  • Saxenda (liraglutide) carries the highest overall gastrointestinal side effect burden of the three and requires daily injections, reducing practical convenience.
  • Dose escalation pace is one of the most controllable factors — a slower titration almost universally results in a more tolerable early experience.
  • Dietary adjustments, hydration, and injection timing are practical tools that meaningfully reduce side effects on any weight loss injection and should be implemented from day one.

When to Seek Professional Advice

Most side effects from weight loss injections are manageable and temporary. However, there are specific situations where you should contact your prescriber or seek urgent medical attention promptly rather than waiting for your next scheduled review.

  • Persistent vomiting that prevents you from keeping fluids down for more than 24 hours — this risks dehydration and electrolyte imbalance.
  • Severe abdominal pain, particularly if it radiates to your back — this warrants urgent assessment to rule out pancreatitis, a rare but serious adverse event associated with GLP-1 class medications.
  • Rapid or irregular heartbeat noted after beginning treatment, which should always be evaluated by a healthcare professional.
  • Significant mood changes or persistent low mood — some users report changes in mental wellbeing on GLP-1 medications, and this should be discussed with your prescriber.
  • Any allergic reaction symptoms including facial swelling, difficulty breathing, or widespread skin rash require immediate emergency attention.
  • If you are considering stopping your injection due to side effects, always speak to your prescriber first — dose adjustments or temporary pauses are often a much better solution than stopping entirely.

Cured Pharmacy's clinical team is available to support patients throughout their treatment, not just at the point of prescription. That ongoing access to professional guidance is one of the most practically important features of using a regulated UK pharmacy service rather than a grey-market supplier. If you are also managing broader wellbeing during weight loss — including supporting energy levels — consider exploring Vitabiotics Wellwoman Original capsules for nutritional support alongside your treatment, always with your prescriber's knowledge.

Scientific References

  1. NICE Technology Appraisal TA875: Tirzepatide for managing overweight and obesity, NICE, 2023 [Accessed 15 August 2026]
  2. NICE Technology Appraisal TA882: Semaglutide (Wegovy) for weight management, NICE, 2023 [Accessed 15 August 2026]
  3. Mounjaro (tirzepatide) Summary of Product Characteristics, electronic Medicines Compendium (eMC), 2023 [Accessed 15 August 2026]
  4. Wegovy (semaglutide 2.4 mg) Summary of Product Characteristics, electronic Medicines Compendium (eMC), 2022 [Accessed 15 August 2026]
  5. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity, New England Journal of Medicine, 2022 [Accessed 15 August 2026]
  6. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine, 2021 [Accessed 15 August 2026]
  7. MHRA Regulatory Approval of Mounjaro (tirzepatide), UK Government/MHRA, 2023 [Accessed 15 August 2026]
  8. MHRA Regulatory Approval of Wegovy (semaglutide), UK Government/MHRA, 2022 [Accessed 15 August 2026]
  9. Diabetes UK: Semaglutide position statement and clinical guidance, Diabetes UK, 2023 [Accessed 15 August 2026]
  10. British National Formulary (BNF): Tirzepatide monograph, NICE/BNF, 2024 [Accessed 15 August 2026]
  11. British National Formulary (BNF): Semaglutide monograph, NICE/BNF, 2024 [Accessed 15 August 2026]
  12. NHS: Obesity treatment options, NHS England, 2024 [Accessed 15 August 2026]
  13. Rubino DM et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (STEP 8), BMJ, 2024 [Accessed 15 August 2026]
  14. Dahl D et al. Efficacy and safety of tirzepatide (SURPASS-5), Lancet Diabetes and Endocrinology, 2022 [Accessed 15 August 2026]
  15. NICE Guideline NG246: Obesity in adults — identification, assessment and management, NICE, 2024 [Accessed 15 August 2026]

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today.

Once you complete a short online assessment, you will be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My AssessmentReturning Customer?Log In to Your Account

Frequently Asked Questions

Which weight loss injection has the fewest side effects compared to others currently available in the UK?

Which weight loss injection has the fewest side effects is most clearly answered by the clinical trial data: Mounjaro (tirzepatide) consistently shows lower rates of nausea and vomiting than Wegovy (semaglutide) at weight-loss doses, with a discontinuation rate below 5% due to side effects in the SURMOUNT trials, making it the most tolerable option for most people.

How long does nausea last when starting a weight loss injection?

How long nausea lasts on a weight loss injection varies by individual, but most people experience peak nausea during the first four to eight weeks of treatment. As the body adjusts to the medication and dose escalation stabilises, nausea typically resolves significantly. Most patients report returning to their normal baseline by week twelve of treatment.

Is it safe to take weight loss injections if you have a sensitive stomach?

Whether weight loss injections are safe for a sensitive stomach depends on your full medical history, which is why a proper prescriber consultation is essential. People with pre-existing gastrointestinal conditions such as gastroparesis should approach GLP-1 medications with caution. Starting at the lowest dose and following dietary guidance carefully can substantially reduce symptoms even for those with digestive sensitivity.

Can you take anything to help with side effects from weight loss injections?

Whether you can take something to help with weight loss injection side effects is a question best answered by your prescriber, as some antiemetics and gut motility agents may interact with these medications. Simple strategies such as dietary changes, injection timing adjustments, and staying well hydrated are often sufficient and should be trialled before adding any additional medication to manage symptoms.

Back to blog